Literature DB >> 25425993

Effect of revascularization of chronic total occlusion on tandem stenoses in a "donor" artery.

Rajesh Sachdeva.   

Abstract

The presence, severity, and extent of ischemia predict the outcome of coronary artery disease. Indeed the extent of myocardial ischemia and viability determines the value of revascularization in coronary stenosis after acute myocardial infarction. In multivessel coronary artery disease, noninvasive methods for the evaluation of ischemia are often inadequate to guide percutaneous coronary intervention. It is a common misperception that revascularization might not benefit a myocardial segment in the chronic total occlusion distribution when that segment is supplied by well-developed collateral vessels, because severe ischemia is unlikely to be present under these circumstances. An 82-year-old man presented with acute coronary syndrome, tandem stenoses in a "donor" artery, and a chronic total occlusion of the right coronary artery. We present a rationale for using fractional flow reserve to determine the existence of ischemia and to aid in deciding the best approach to the treatment of that ischemia.

Entities:  

Keywords:  Acute coronary syndrome/therapy; coronary occlusion/therapy; coronary stenosis/diagnosis; decision making; fractional flow reserve, myocardial; myocardial revascularization/methods; percutaneous coronary intervention; stents

Mesh:

Year:  2014        PMID: 25425993      PMCID: PMC4189362          DOI: 10.14503/THIJ-13-3569

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  6 in total

1.  Pressure-derived fractional flow reserve to assess serial epicardial stenoses: theoretical basis and animal validation.

Authors:  B De Bruyne; N H Pijls; G R Heyndrickx; D Hodeige; R Kirkeeide; K L Gould
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

2.  The effect of CTO recanalization on FFR of the donor artery.

Authors:  Rajesh Sachdeva; Barry F Uretsky
Journal:  Catheter Cardiovasc Interv       Date:  2011-02-15       Impact factor: 2.692

3.  Fractional flow reserve in patients with prior myocardial infarction.

Authors:  B De Bruyne; N H Pijls; J Bartunek; K Kulecki; J W Bech; H De Winter; P Van Crombrugge; G R Heyndrickx; W Wijns
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

4.  The functional reserve of collaterals supplying long-term chronic total coronary occlusions in patients without prior myocardial infarction.

Authors:  Gerald S Werner; Ralf Surber; Markus Ferrari; Michael Fritzenwanger; Hans R Figulla
Journal:  Eur Heart J       Date:  2006-09-26       Impact factor: 29.983

5.  Comparison between angiography and fractional flow reserve versus single-photon emission computed tomographic myocardial perfusion imaging for determining lesion significance in patients with multivessel coronary disease.

Authors:  Michael Ragosta; Andrew H Bishop; Lewis C Lipson; Denny D Watson; Lawrence W Gimple; Ian J Sarembock; Eric R Powers
Journal:  Am J Cardiol       Date:  2007-02-12       Impact factor: 2.778

6.  ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.

Authors:  Manesh R Patel; Gregory J Dehmer; John W Hirshfeld; Peter K Smith; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2009-02-10       Impact factor: 24.094

  6 in total
  1 in total

1.  Donor artery stenosis interactions with diastolic blood pressure on coronary collateral flow in type 2 diabetic patients with chronic total occlusion.

Authors:  Ying Shen; Zhen Kun Yang; Jian Hu; Xiao Qun Wang; Yang Dai; Su Zhang; Rui Yan Zhang; Lin Lu; Feng Hua Ding; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2018-06-01       Impact factor: 9.951

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.